Keurig Dr Pepper (NASDAQ:KDP – Get Free Report) was downgraded by equities researchers at Hsbc Global Res from a “strong-buy” rating to a “hold” rating in a research report issued on Tuesday,Zacks.com reports.
KDP has been the topic of a number of other reports. Barclays raised their price target on Keurig Dr Pepper from $37.00 to $39.00 and gave the company an “overweight” rating in a report on Monday, July 28th. Jefferies Financial Group set a $41.00 target price on Keurig Dr Pepper in a report on Monday. HSBC reaffirmed a “hold” rating and set a $30.00 target price (down from $42.00) on shares of Keurig Dr Pepper in a report on Tuesday. Deutsche Bank Aktiengesellschaft lowered their target price on Keurig Dr Pepper from $40.00 to $38.00 and set a “buy” rating on the stock in a report on Tuesday. Finally, UBS Group lowered their target price on Keurig Dr Pepper from $42.00 to $40.00 and set a “buy” rating on the stock in a report on Thursday, July 17th. Eleven research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $38.38.
Check Out Our Latest Stock Report on Keurig Dr Pepper
Keurig Dr Pepper Price Performance
Keurig Dr Pepper (NASDAQ:KDP – Get Free Report) last issued its quarterly earnings results on Thursday, July 24th. The company reported $0.49 EPS for the quarter, meeting analysts’ consensus estimates of $0.49. The company had revenue of $4.16 billion for the quarter, compared to analyst estimates of $4.14 billion. Keurig Dr Pepper had a return on equity of 11.05% and a net margin of 9.75%.The company’s quarterly revenue was up 6.1% compared to the same quarter last year. During the same period last year, the company earned $0.45 earnings per share. Equities analysts anticipate that Keurig Dr Pepper will post 1.92 EPS for the current year.
Insider Buying and Selling
In related news, insider Mary Beth Denooyer sold 12,000 shares of Keurig Dr Pepper stock in a transaction dated Thursday, July 17th. The stock was sold at an average price of $33.66, for a total value of $403,920.00. Following the transaction, the insider owned 82,511 shares of the company’s stock, valued at approximately $2,777,320.26. This trade represents a 12.70% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Robert James Gamgort sold 208,000 shares of Keurig Dr Pepper stock in a transaction dated Friday, August 1st. The stock was sold at an average price of $32.90, for a total value of $6,843,200.00. Following the completion of the transaction, the director directly owned 2,292,169 shares in the company, valued at $75,412,360.10. This represents a 8.32% decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 679,601 shares of company stock valued at $22,508,712. 0.40% of the stock is owned by corporate insiders.
Institutional Investors Weigh In On Keurig Dr Pepper
Institutional investors have recently bought and sold shares of the business. Rise Advisors LLC acquired a new stake in Keurig Dr Pepper during the 1st quarter worth about $25,000. Chung Wu Investment Group LLC acquired a new stake in Keurig Dr Pepper during the 2nd quarter worth about $26,000. NewSquare Capital LLC boosted its position in Keurig Dr Pepper by 94.1% during the 2nd quarter. NewSquare Capital LLC now owns 796 shares of the company’s stock worth $26,000 after acquiring an additional 386 shares during the period. AlphaCore Capital LLC acquired a new stake in Keurig Dr Pepper during the 2nd quarter worth about $26,000. Finally, ST Germain D J Co. Inc. acquired a new stake in Keurig Dr Pepper during the 1st quarter worth about $27,000. 93.99% of the stock is currently owned by institutional investors and hedge funds.
Keurig Dr Pepper Company Profile
Keurig Dr Pepper Inc owns, manufactures, and distributors beverages and single serve brewing systems in the United States and internationally. It operates through three segments: U.S. Refreshment Beverages, U.S. Coffee, and International. The U.S. Refreshment Beverages segment manufactures and distributes branded concentrates, syrup, and finished beverages.
Featured Stories
- Five stocks we like better than Keurig Dr Pepper
- Health Care Stocks Explained: Why You Might Want to Invest
- Amazon’s Chart Just Flashed a Pennant Pattern—Here’s What to Do
- Investing in the High PE Growth Stocks
- 3 Undervalued Stocks Analysts Are Loving Right Now—Should You?
- Russell 2000 Index, How Investors Use it For Profitable Trading
- Williams-Sonoma Q2 Results Prove Its Buy-and-Hold Quality
Receive News & Ratings for Keurig Dr Pepper Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Keurig Dr Pepper and related companies with MarketBeat.com's FREE daily email newsletter.